Publications by authors named "Pascal Pommier"

Claim this Profile
S
Stereotactic Intensity-modulated Radiotherapy After Radical Prostatectomy (SCIMITAR): 4-Year Outcomes of a Phase 2 Clinical Trial.
Amar U Kishan, Jesus E Juarez Casillas, Paul Sargos, Tahmineh Romero Kalbasi, Sylvie Chabaud, Pascal Pommier

Eur Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant radiotherapy in patients with pathological high-risk bladder cancer: Acute toxicity results from a randomized multicentre phase II trial (Bladder-ART/GETUG-AFU30).
Paul Sargos, Géraldine Pignot, Carine Bellera, Pascal Pommier, Etienne Martin

Radiother Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best practice in brachytherapy: 2025 update.
Jean-Michel Hannoun-Lévi, Sophie Renard, Pascal Pommier, Lucie Houdou, Fabien Mignot

Cancer Radiother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial.
Nicolas Demogeot, Paul Sargos, Julia Salleron, Stéphane Guérif, Renaud de Crevoisier, Pascal Pommier

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose-rate (HDR) plesiotherapy with flap for the treatment of non-melanoma skin cancer.
Quentin Josset, Catherine Guerin-Charbonnel, Nathalie Nebout, Maxime Bremaud, Pascal Pommier

Pract Radiat Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data.
Sarah Burdett, David J Fisher, Jayne F Tierney, Adrian D Cook, Daniel E Spratt, Pascal Pommier

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Relapse Following Radiation Therapy of Intermediate-Risk Prostate Cancer in the PROFIT Randomized Trial.
Martin Langé, Loïc Campion, Luc Ollivier, Marion Renouf, Nicolas Magné, Pascal Pommier

Int J Radiat Oncol Biol Phys· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysis.
Najlaa Alyamani, Enrico Clementel, Paul Sargos, Pierre Blanchard, Stephane Supiot, Pascal Pommier

Radiother Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial.
Loic Ah-Thiane, Loic Campion, Nedjla Allouache, Emmanuel Meyer, Pascal Pommier

Eur Urol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07).
Loig Vaugier, Cyrille Morvan, David Pasquier, Xavier Buthaud, Nicolas Magné, Pascal Pommier

Eur Urol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: A comparative analysis of the French cohort FFCD-ANABASE.
Chloé Buchalet, Claire Lemanski, Pascal Pommier, Karine Le Malicot, Nathalie Bonichon-Lamichhane

Dig Liver Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors in post-prostatectomy salvage radiotherapy setting with and without hormonotherapy: An individual patient data analysis of randomized trials from ICECaP database.
Pascal Pommier, Wanling Xie, Praful Ravi, Christian Carrie, James J Dignam

Radiother Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASE.
Cecile Evin, Laurent Quéro, Karine Le Malicot, Sarah Blanchet-Deverly, Ludovic Evesque, Pascal Pommier

Int J Radiat Oncol Biol Phys· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Practice-changing trials: Urological radiation oncology].
Pierre Graff, Pascal Pommier, Mathieu Minsat, Gilles Créhange

Cancer Radiother· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials.
Lucia Kwak, Praful Ravi, John G Armstrong, Veronique Beckendorf, Joseph L Chin, Pascal Pommier

J Clin Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines.
Raquel Dávila Fajardo, Giovanni Scarzello, Mark N Gaze, Tom Boterberg, Alison Cameron, Pascal Pommier

Radiother Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial.
Lionel Perrier, Frédéric Balusson, Magali Morelle, Joël Castelli, Juliette Thariat, Pascal Pommier

Radiother Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.
Claire Gouriou, Claire Lemanski, Pascal Pommier, Karine Le Malicot, Angélique Saint

Br J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultra-hypofractionated prostate cancer radiotherapy: Dosimetric impact of real-time intrafraction prostate motion and daily anatomical changes.
Francesca di Franco, Thomas Baudier, Pierre Marie Pialat, Alexandre Munoz, Murielle Martinon, Pascal Pommier

Phys Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.
Ingrid Masson, Laurène Larriviere, Marc-André Mahé, David Azria, Pascal Pommier

Clin Transl Radiat Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study.
Nicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, Gianluca Ingrosso, Mario Di Staso, Pascal Pommier

Eur Urol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer: A Phase 3 Randomized Clinical Trial.
Joël Castelli, Juliette Thariat, Karen Benezery, Ali Hasbini, Bernard Gery, Pascal Pommier

JAMA Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial.
David Pasquier, Philippe Nickers, Didier Peiffert, Philippe Maingon, Pascal Pommier

Eur Urol Open Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol.
Maximilien Rogé, Yoann Pointreau, Paul Sargos, Emmanuel Meyer, Ulrike Schick, Pascal Pommier

Clin Transl Radiat Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resident training in brachytherapy in France: A 10-year update after the first survey of SFJRO members.
Manon Kissel, Luc Ollivier, Ingrid Fumagalli, Pascal Pommier, Cyrus Chargari

J Contemp Brachytherapy· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis